Development of extracellular vesicle-based medicinal products: A position paper of the group "Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France".
Adv Drug Deliv Rev
Targeted alpha particle therapy remodels the tumor microenvironment and improves efficacy of immunotherapy.
Int J Radiat Oncol Biol Phys
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome.
JAMA Netw Open
Value of FDG-PET/CT in monitoring cyst infections in patients with autosomal dominant polycystic renal disease.
Clin Kidney J
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.
Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist.
24th "Nantes Actualités en Transplantation" and 4th "LabEx Immunotherapy-Graft-Oncology" NAT and IGO Joint Meeting "New Horizons in Immunotherapy".
CD8+ T cells variably recognize native versus citrullinatedGRP78 epitopes in type 1 diabetes.